Navigation Links
Amnioinfusion does not reduce risk of meconium aspiration syndrome

Meconium aspiration syndrome (also referred to as meconium aspiration) occurs when a newborn inhales a mixture of meconium and amniotic fluid during labor and delivery.

Meconium is the material that fills the fetal intestinal tract during pregnancy and is formed from ingested amniotic fluid and dead intestinal cells.// Although it is sterile, inhaled meconium is highly irritating to the lung when the infant takes its first breaths. It can cause a partial or complete blockage of the baby's airways when exhaling, making it difficult to breathe.

Meconium alters the amniotic fluid, reducing antibacterial activity and subsequently increasing the risk of perinatal bacterial infection. Meconium-stained amniotic fluid occurs in 7 to 22% of term deliveries. In anywhere from 2% to more than a third of these deliveries, MAS can occur.

Aspiration induces 3 major pulmonary effects, which are airway obstruction, surfactant dysfunction, and chemical pneumonitis.

One of the techniques used in preventing this syndrome in children is amnioinfusion. This technique involves infusing saline, though a small synthetic tube into the amniotic cavity of women in labour who show heavy meconium.

Amnioinfusion is intended to reduce the risk of MAS by diluting the meconium.

A recent study has revealed that amnioinfusion, the infusion of saline into the uterus, does not reduce the risk of meconium aspiration syndrome (MAS), as previously believed.

The rigorous study methods and international scope of this trial provides very strong evidence against the use of amnioinfusion, and the results are likely to have a major impact on childbirth practices around the world.

Page: 1

Related medicine news :

1. Stress reduces your immunity- startling but true!!!!!
2. Risk of Cancer can be reduced to 40% with a High Fiber Diet
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Aspirin reduces deaths
5. Stop smoking and reduce weight
6. Statins reduce heart attacks
7. Vitamins reduce pre-eclampsia
8. Exercises reduce risks of cancers
9. Frequent meals can reduce cholesterol
10. Tomato Sauce reduces Cancer Risk- Study
11. Contraceptive pill to reduce PMS
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: